SEVERE PREECLAMPSIA

Clinical trials for SEVERE PREECLAMPSIA explained in plain language.

Never miss a new study

Get alerted when new SEVERE PREECLAMPSIA trials appear

Sign up with your email to follow new studies for SEVERE PREECLAMPSIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 5 Completed 2 Terminated 1

Promising preeclampsia drug trial halted early – what happened?

Disease control Terminated

This study tested an experimental drug called AMAG-423 (Digoxin Immune Fab) in pregnant women with severe preeclampsia, a dangerous condition of high blood pressure during pregnancy. The goal was to see if the drug could reduce serious health problems in babies, such as bleeding …

Matched conditions: SEVERE PREECLAMPSIA

Phase: PHASE2, PHASE3 • Sponsor: AMAG Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:36 UTC

SEVERE PREECLAMPSIA

Get alerted when new SEVERE PREECLAMPSIA trials appear

Promising preeclampsia drug trial halted early – what happened?